Detection of high-risk subtypes of human papillomavirus in cervical swabs: routine use of the Digene Hybrid Capture assay and polymerase chain reaction analysis.
AffiliationDepartment of Histopathology, Cytology and Gynaecology, Cork University Hospital,, Wilton, Cork, Ireland.
In Situ Hybridization/methods
Polymerase Chain Reaction/methods
Sensitivity and Specificity
Uterine Cervical Neoplasms/virology
MetadataShow full item record
CitationBr J Biomed Sci. 2001;58(1):24-9.
JournalBritish journal of biomedical science
AbstractHuman papillomaviruses (HPVs) are major causative agents in the pathogenesis of cervical cancer, and more than twenty types are associated with its development. With the introduction of liquid-based preparation systems, it is envisaged that large-scale HPV testing will be established in the near future. Preliminary studies demonstrate the accessibility of these samples for DNA testing using both the Digene Hybrid Capture assay (DHCA) and polymerase chain reaction (PCR) techniques. This study aims to assess the validity and sensitivity of the DHCA system to detect high-risk HPV DNA, using two sets of HPV consensus primers (Gp5+/Gp6+ and MY09/MY11) in tandem with routine assessment of cervical smear and biopsy samples. Results indicate that the combination of DHCA and PCR detects more high-grade lesions than does the DHCA alone. DHCA-negative cases were categorised by subsequent PCR amplification into low-grade HPV-negative (12/16) cervical lesions and high-grade HPV-positive (7/9) cervical lesions. Gp5+/Gp6+ primers were less sensitive in detecting HPV-positive samples than was the MY09/MY11 primer set. These results support the use of high-risk HPV testing by DHCA, with subsequent analysis of DHCA-negative samples by PCR using the MY09/MY11 primers.
- Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.
- Authors: Szostek S, Klimek M, Zawilinska B, Rys J, Kope J, Daszkiewic E
- Issue date: 2006
- [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
- Authors: Ergünay K, Misirlioğlu M, Firat P, Tuncer ZS, Tuncer S, Yildiz I, Ustaçelebi S
- Issue date: 2008 Apr
- Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
- Authors: Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seilles E, Mougin C
- Issue date: 1999 Sep
- Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens.
- Authors: Husnjak K, Grce M, Magdić L, Pavelić K
- Issue date: 2000 Aug
- Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.
- Authors: Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE
- Issue date: 2006 Jul